GPCR
Structure Therapeutics Inc. American Depositary Shares
NASDAQ: GPCR · HEALTHCARE · BIOTECHNOLOGY
$41.37
-5.04% today
Updated 2026-04-29
Market cap
$2.94B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.40
Dividend yield
—
52W range
$16 – $95
Volume
1.0M
Structure Therapeutics Inc. American Depositary Shares (GPCR) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-14.28M | $-32.16M | $-46.12M | $-79.49M | $-116.64M | $-222.20M |
| Capital expenditures | $19000.00 | $1.21M | $155000.00 | $2.17M | $1.29M | $3.61M |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $570000.00 | $1.49M | $2.51M | $8.19M | $18.79M | $28.99M |
| Free cash flow | $-14.30M | $-33.37M | $-46.27M | $-81.66M | $-117.93M | $-225.81M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |